Highlights
- Market Cap
- $2.60B
- Enterprise Value
- $2.57B
- EPS (TTM)
- $0.01
- PE Ratio
- 1,586.35
- Total Revenue (TTM)
- $871.91M
- Gross Profit (TTM)
- $470.58M
- EBITDA (TTM)
- $34.02M
- Year Range
- $13.63 - $31.00
- Target Price
- $29.33
- ROA (TTM)
- 0.23%
- ROE (TTM)
- 0.45%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Warby Parker Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Warby Parker Inc. (WRBY) has returned -3.30% so far this year and 15.58% over the past 12 months.
Warby Parker Inc.
- 1D
- 3.59%
- 1M
- -15.75%
- YTD
- -3.30%
- 6M
- -23.60%
- 1Y
- 15.58%
- 3Y*
- 25.77%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Sep 29, 2021, WRBY's average daily return is 0.00%, while the average monthly return is -0.17%.
Historically, 53% of months were positive and 47% were negative. The best month was May 2024 with a return of +50.9%, while the worst month was Jun 2022 at -33.7%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, WRBY closed higher 47% of trading days. The best single day was Dec 10, 2025 with a return of +27.4%, while the worst single day was Nov 8, 2023 at -24.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.07% | -1.96% | -15.75% | -3.30% | |||||||||
| 2025 | 14.46% | -10.75% | -26.28% | -9.43% | 28.23% | 3.59% | 9.21% | 9.39% | 5.27% | -28.97% | 1.12% | 9.99% | -10.00% |
| 2024 | -9.57% | -0.31% | 7.08% | -13.74% | 50.85% | -9.32% | 2.55% | -9.41% | 9.45% | 3.67% | 33.14% | 7.41% | 71.70% |
| 2023 | 19.72% | -19.44% | -18.60% | -0.57% | 4.56% | 6.18% | 27.80% | -19.61% | 9.58% | -1.37% | -19.80% | 35.45% | 4.52% |
| 2022 | -20.17% | -19.48% | 12.96% | -31.12% | -27.09% | -33.69% | 10.04% | 1.45% | 6.13% | 20.31% | 6.11% | -20.79% | -71.03% |
| 2021 | -2.64% | 1.79% | -6.02% | -8.26% | -14.55% |
Benchmark Metrics
Warby Parker Inc. has an annualized alpha of -18.10%, beta of 1.92, and R² of 0.26 versus S&P 500 Index. Calculated based on daily prices since September 30, 2021.
- This stock participated in 204.74% of S&P 500 Index downside but only 132.55% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.26 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -18.10%
- Beta
- 1.92
- R²
- 0.26
- Upside Capture
- 132.55%
- Downside Capture
- 204.74%
Return for Risk
Risk / Return Rank
WRBY ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Warby Parker Inc. (WRBY) and compare them to a chosen benchmark (S&P 500 Index).
| WRBY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.22 | 0.90 | -0.68 |
Sortino ratioReturn per unit of downside risk | 0.93 | 1.39 | -0.45 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.21 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.40 | -1.09 |
Martin ratioReturn relative to average drawdown | 0.73 | 6.61 | -5.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore WRBY risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Warby Parker Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Warby Parker Inc. was 83.71%, occurring on Mar 17, 2023. The portfolio has not yet recovered.
The current Warby Parker Inc. drawdown is 64.59%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -83.71% | Nov 18, 2021 | 333 | Mar 17, 2023 | — | — | — |
| -9.76% | Nov 9, 2021 | 3 | Nov 11, 2021 | 4 | Nov 17, 2021 | 7 |
| -9.18% | Sep 30, 2021 | 7 | Oct 8, 2021 | 5 | Oct 15, 2021 | 12 |
| -8.52% | Oct 26, 2021 | 4 | Oct 29, 2021 | 6 | Nov 8, 2021 | 10 |
| -0.96% | Oct 19, 2021 | 4 | Oct 22, 2021 | 1 | Oct 25, 2021 | 5 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Warby Parker Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Warby Parker Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for WRBY, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, WRBY has a P/E ratio of 1,586.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for WRBY relative to other companies in the Medical Instruments & Supplies industry. Currently, WRBY has a P/S ratio of 3.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for WRBY in comparison with other companies in the Medical Instruments & Supplies industry. Currently, WRBY has a P/B value of 7.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |